Skip to content
DataLookout
Menu

BMINCT07906626

Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Interventions: Snakehead Fish Extract and Curcumin (Drug) to Placebo (Drug), Snakehead Fish Extract and Curcumin (Drug)
    • Study arms: 1 to 2
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Change from baseline in body weight at 9 weeks
Timeframe: Baseline and After 9 weeks

Secondary (8)

Change from baseline in serum C-reactive protein (CRP) levels at 9 weeks
Change from baseline in serum tumor necrosis factor-alpha (TNF-alpha) levels at 9 weeks
Change from baseline in serum interleukin-6 (IL-6) levels at 9 weeks
Change from baseline in mid-upper arm circumference (MUAC) at 9 weeks
Change from baseline in Body Mass Index (BMI) at 9 weeks
Show 3 moreShow less
Change from baseline in EORTC QLQ-C30 functional scale scores at 9 weeks
Change from baseline in EORTC QLQ-C30 symptom scale scores at 9 weeks
Change from baseline in EORTC QLQ-C30 global health status score at 9 weeks

Arms and interventions

INTERVENTIONExperimental
PLACEBOExperimental

Participants receive matching placebo capsules containing inert substances (e.g., starch/fillers) administered at the same frequency and duration (2 capsules 3 times daily for 3 months) to match the intervention regimen.

Drugs: Snakehead Fish Extract and Curcumin, Placebo

Sites

1 site in 1 country

  • Universitas Sumatera UtaraMedan, North Sumatra, Indonesia